394 related articles for article (PubMed ID: 25579325)
1. Antinociceptive effect of intracerebroventricular administration of glycine transporter-2 inhibitor ALX1393 in rat models of inflammatory and neuropathic pain.
Takahashi Y; Hara K; Haranishi Y; Terada T; Obara G; Sata T
Pharmacol Biochem Behav; 2015 Mar; 130():46-52. PubMed ID: 25579325
[TBL] [Abstract][Full Text] [Related]
2. The antinociceptive effect of intrathecal administration of glycine transporter-2 inhibitor ALX1393 in a rat acute pain model.
Haranishi Y; Hara K; Terada T; Nakamura S; Sata T
Anesth Analg; 2010 Feb; 110(2):615-21. PubMed ID: 20081141
[TBL] [Abstract][Full Text] [Related]
3. Effects of intrathecal and intracerebroventricular administration of luteolin in a rat neuropathic pain model.
Hara K; Haranishi Y; Terada T; Takahashi Y; Nakamura M; Sata T
Pharmacol Biochem Behav; 2014 Oct; 125():78-84. PubMed ID: 25196931
[TBL] [Abstract][Full Text] [Related]
4. Antinociceptive effect of intrathecal administration of hypotaurine in rat models of inflammatory and neuropathic pain.
Hara K; Nakamura M; Haranishi Y; Terada T; Kataoka K; Sata T
Amino Acids; 2012 Jul; 43(1):397-404. PubMed ID: 21971909
[TBL] [Abstract][Full Text] [Related]
5. Long-term application of glycine transporter inhibitors acts antineuropathic and modulates spinal N-methyl-D-aspartate receptor subunit NR-1 expression in rats.
Barthel F; Urban A; Schlösser L; Eulenburg V; Werdehausen R; Brandenburger T; Aragon C; Bauer I; Hermanns H
Anesthesiology; 2014 Jul; 121(1):160-9. PubMed ID: 24598217
[TBL] [Abstract][Full Text] [Related]
6. Chlorogenic acid administered intrathecally alleviates mechanical and cold hyperalgesia in a rat neuropathic pain model.
Hara K; Haranishi Y; Kataoka K; Takahashi Y; Terada T; Nakamura M; Sata T
Eur J Pharmacol; 2014 Jan; 723():459-64. PubMed ID: 24184666
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of spinally applied glycine transporter inhibitors on nociception in a rat model of neuropathic pain.
Hermanns H; Muth-Selbach U; Williams R; Krug S; Lipfert P; Werdehausen R; Braun S; Bauer I
Neurosci Lett; 2008 Nov; 445(3):214-9. PubMed ID: 18793697
[TBL] [Abstract][Full Text] [Related]
8. Antinociceptive effect of intrathecal administration of taurine in rat models of neuropathic pain.
Terada T; Hara K; Haranishi Y; Sata T
Can J Anaesth; 2011 Jul; 58(7):630-637. PubMed ID: 21512835
[TBL] [Abstract][Full Text] [Related]
9. Spinal antiallodynia action of glycine transporter inhibitors in neuropathic pain models in mice.
Morita K; Motoyama N; Kitayama T; Morioka N; Kifune K; Dohi T
J Pharmacol Exp Ther; 2008 Aug; 326(2):633-45. PubMed ID: 18448867
[TBL] [Abstract][Full Text] [Related]
10. Antihyperalgesic effects of intrathecal perospirone in a rat model of neuropathic pain.
Haranishi Y; Hara K; Terada T
Pharmacol Biochem Behav; 2020 Aug; 195():172964. PubMed ID: 32504731
[TBL] [Abstract][Full Text] [Related]
11. The antinociceptive effect of SNAP5114, a gamma-aminobutyric acid transporter-3 inhibitor, in rat experimental pain models.
Kataoka K; Hara K; Haranishi Y; Terada T; Sata T
Anesth Analg; 2013 May; 116(5):1162-1169. PubMed ID: 23456665
[TBL] [Abstract][Full Text] [Related]
12. Glycine transporter GlyT1, but not GlyT2, is expressed in rat dorsal root ganglion--Possible implications for neuropathic pain.
Schlösser L; Barthel F; Brandenburger T; Neumann E; Bauer I; Eulenburg V; Werdehausen R; Hermanns H
Neurosci Lett; 2015 Jul; 600():213-9. PubMed ID: 26101830
[TBL] [Abstract][Full Text] [Related]
13. Antinociceptive activity of α4β2* neuronal nicotinic receptor agonist A-366833 in experimental models of neuropathic and inflammatory pain.
Nirogi R; Jabaris SL; Jayarajan P; Abraham R; Shanmuganathan D; Rasheed MA; Royapalley PK; Goura V
Eur J Pharmacol; 2011 Oct; 668(1-2):155-62. PubMed ID: 21756895
[TBL] [Abstract][Full Text] [Related]
14. The antihyperalgesic effect of cytidine-5'-diphosphate-choline in neuropathic and inflammatory pain models.
Bagdas D; Sonat FA; Hamurtekin E; Sonal S; Gurun MS
Behav Pharmacol; 2011 Sep; 22(5-6):589-98. PubMed ID: 21836465
[TBL] [Abstract][Full Text] [Related]
15. Glycine transporter inhibitors as a novel drug discovery strategy for neuropathic pain.
Dohi T; Morita K; Kitayama T; Motoyama N; Morioka N
Pharmacol Ther; 2009 Jul; 123(1):54-79. PubMed ID: 19393690
[TBL] [Abstract][Full Text] [Related]
16. Antihyperalgesic, Antiallodynic, and Antinociceptive Effects of Cebranopadol, a Novel Potent Nociceptin/Orphanin FQ and Opioid Receptor Agonist, after Peripheral and Central Administration in Rodent Models of Neuropathic Pain.
Tzschentke TM; Linz K; Frosch S; Christoph T
Pain Pract; 2017 Nov; 17(8):1032-1041. PubMed ID: 28112482
[TBL] [Abstract][Full Text] [Related]
17. Intrathecally administered perampanel alleviates neuropathic and inflammatory pain in rats.
Hara K; Haranishi Y; Terada T
Eur J Pharmacol; 2020 Apr; 872():172949. PubMed ID: 31991141
[TBL] [Abstract][Full Text] [Related]
18. The antinociceptive effect of acetaminophen in a rat model of neuropathic pain.
Im KS; Jung HJ; Kim JB; Lee JM; Park HJ; Joo CH; Moon DE
Kaohsiung J Med Sci; 2012 May; 28(5):251-8. PubMed ID: 22531303
[TBL] [Abstract][Full Text] [Related]
19. Verbascoside administered intrathecally attenuates hyperalgesia via activating mu-opioid receptors in a rat chronic constriction injury model.
Hara K; Haranishi Y; Terada T
Eur J Pain; 2022 Jul; 26(6):1322-1332. PubMed ID: 35437876
[TBL] [Abstract][Full Text] [Related]
20. Glycine transporter inhibitors: A new avenue for managing neuropathic pain.
Al-Khrasani M; Mohammadzadeh A; Balogh M; Király K; Barsi S; Hajnal B; Köles L; Zádori ZS; Harsing LG
Brain Res Bull; 2019 Oct; 152():143-158. PubMed ID: 31302238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
